Dynamic Roles of RNA and RNA Epigenetics in HTLV-1 Biology

Area of Science:

• Virology
• Molecular Biology
• Genomics

Background:

• RNA's role extends beyond protein coding, significantly impacting viral replication and host interactions.
• Human T-cell leukemia virus type 1 (HTLV-1) extensively utilizes RNA for its lifecycle, pathogenesis, and immune evasion.
• Recent advancements in sequencing technologies have enhanced the study of RNA modifications and splice variants.

Purpose of the Study:

• To review the dynamic roles of RNA and its post-transcriptional epigenetic modifications in HTLV-1 biology.
• To highlight specific RNA elements and modifications, including viral *hbz*, lncRNAs, miRNAs, tRNAs, R-loops, and m6A.
• To discuss the potential of RNA-based therapeutics and vaccines against HTLV-1.

Main Methods:

• Review of current scientific literature on HTLV-1 RNA biology.
• Focus on insights gained from third-generation sequencing technologies like Oxford Nanopore sequencing.
• Integration of knowledge on RNA epigenetic modifications and splice variants.

Main Results:

• RNA epigenetic modifications and splice variants play critical roles in HTLV-1 replication, persistence, and oncogenesis.
• Specific RNA molecules and modifications, such as viral *hbz* and N6-methyladenosine (m6A), are key regulators.
• Understanding these RNA elements opens avenues for novel therapeutic and vaccine strategies.

Conclusions:

• RNA modifications are integral to HTLV-1 pathogenesis and viral evasion mechanisms.
• Third-generation sequencing facilitates deeper understanding of complex RNA landscapes in HTLV-1.
• Targeting RNA-based mechanisms offers promising strategies for HTLV-1 treatment and prevention.